News & Blog

Tag Archives: FDA

Potential Glioblastoma Treatments Entering The Pivotal Phase of Evaluation

Jump Ahead to List of Trials Glioblastoma (GBM) is the most common and aggressive malignant brain tumor and, regrettably, very limited treatment options exist for these patients. The current standard-of-care for newly diagnosed patients is surgery, followed by radiation and chemotherapy (with temozolomide), and, in some cases, use of the tumor-treating-field device, Optune. If and […]

From the CEO’s Desk: Know Your Options – A New Resource for Brain Tumor Patients

The new NBTS Clinical Trial Finder will make it easier for brain tumor patients to find up-to-date information on clinical trials, enabling patients to better engage with medical research and make more informed decisions about their own treatment options – including clinical trials – in the emerging era of precision medicine. Dear Brain Tumor Community: […]

60 Minutes, the poliovirus, and Breakthrough Therapy Designation

Since the news program “60 Minutes” first aired two segments in March 2015 focused on an early-phase clinical trial taking place at Duke University, a lot of excitement has been generated about the investigational treatment highlighted: PVS-RIPO – more commonly referred to as the re-engineered poliovirus. The excitement was well-warranted, as the results reported at […]

Share